0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinicopathologic Reports, Case Reports, and Small Case Series |

Orbital Ganglioneuroma in a Patient With Chronic Progressive Proptosis FREE

Thomas C. Cannon, MD; Harry H. Brown, MD; Bradley M. Hughes, MD; Alyssa N. Wenger, MD; Steven B. Flynn, MD, PhD; Christopher T. Westfall, MD
[+] Author Affiliations

Section Editor: W. Richard Green, MD

More Author Information
Arch Ophthalmol. 2004;122(11):1712-1714. doi:10.1001/archopht.122.11.1712.
Text Size: A A A
Published online

Ganglioneuromas are rare benign neoplasms of neuroblastic origin thathave been reported in multiple anatomic locations. Orbital involvement isextremely rare, with only a single reported case of direct extension to theorbit from an adjacent parasinus. This is the first reported case of a ganglioneuromaarising in the orbit.

A 12-year-old African American male had progressive proptosis of theright eye during a 1-year period (Figure 1).The child had a history of stage IV neuroblastoma 10 years earlier that hadoriginated in the adrenal gland and was treated with 7 courses of cyclophosphamideand teniposide after induction with adriamycin and cyclophosphamide. Neuroblastomawith metastases was confirmed by biopsy of the adrenal gland prior to inductionof chemotherapy. No additional surgery was performed because of the advancedstage of the disease, and the patient responded to chemotherapy and remainedin remission. His past medical history also included multiple cutaneous ganglioneuromasof the abdomen and gastrointestinal ganglioneuromas. He was profoundly mentallyhandicapped since infancy. Eye examination revealed no light perception inboth eyes. He had 4 mm of proptosis of the right eye. His pupils were slowlyreactive to light with no afferent pupillary defect. The cornea of the righteye evidenced diffuse punctate epithelial erosions and moderate conjunctivalinjection. Results of an anterior segment examination of the left eye werenormal. Ductions were full in both eyes. Dilated funduscopic examination revealedoptic nerve pallor with cup to disc ratio of 0.6 in both eyes. The macula,retina, and vitreous were normal in both eyes.

Place holder to copy figure label and caption
Figure 1.

Clinical photograph prior to surgeryshowing proptosis of the right eye.

Graphic Jump Location

Magnetic resonance imaging revealed a lobulated neoplasm of the rightsuperior orbit that molded around the globe (Figure 2 and Figure 3). Theneoplasm was enhanced with contrast and appeared homogeneous in composition.There was no evidence of involvement of the bone. Orbital exploration viaan anterior orbitotomy incision revealed a circumscribed lesion with a gray-tansurface without necrosis (Figure 4).Histopathologic examination of an incisional biopsy revealed neural tissuecontainingmature ganglion cells, and no neuroblastic elements were pres-ent.Because of progressive proptosis and corneal exposure, debulking was performed.Extensive histologic sampling revealed the neoplasm to be composed entirelyof mature ganglioneuromatous tissue; again, no foci of neuroblastoma or sarcomawere detected (Figure 5). Immunohistochemicalstains showed ganglion cells exhibiting strong cytoplasmic positivity forneuron-specific enolase and synaptophysin; only occasional ganglion cellsdemonstrated weak positivity for neurofilament and S-100 protein. The spindlecell component of the neoplasm demonstrated strong cytoplasmic positivityfor S-100 protein, neurofilament, synaptophysin, and neuron-specific enolase.The immunohistochemical findings are consistent with ganglioneuroma.1

Place holder to copy figure label and caption
Figure 2.

Axial view of an orbital T1-weightedmagnetic resonance image revealing a superior orbital neoplasm.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Coronal view of an orbital T1-weightedmagnetic resonance image showing a neoplasm without invasion of the bone.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.

bo Gross photograph of the neoplasmshowing a circumscribed lesion with a variegated tan-white surface lackingnecrosis.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 5.

Hematoxylin-eosin staining showingmature ganglion cells within a neurofibrillary matrix and no neuroblastoma(original magnification × 200).

Graphic Jump Location

Neuroblastic neoplasms can be broadly subcategorized as neuroblastoma,ganglioneuroblastoma, or ganglioneuroma.2 Ganglioneuromasare benign neoplasms composed of neural elements, including mature ganglioncells. Grossly, ganglioneuromas appear circumscribed with a gray or tan cutsurface having a whorled appearance on sectioning. In addition to its associationwith metastatic neuroblastoma, ganglioneuroma has been associated with neurofibromatosistype 13 and multiple endocrine neoplasia.4 Ganglioneuromas of the gastrointestinal tract arenot uncommon in the neurofibromatosis. They also commonly arise from the sympatheticchain and can be found in the retroperitoneum or posterior mediastinum.5 A single orbital case has been documented that describedlocal extension from the sinuses.6 Metastasesdo not occur; however, patients who have had metastatic neuroblastoma maydevelop ganglioneuromas that are thought to represent rests of neuroblastomacells that have undergone differentiation to ganglioneuromas.7 Theseneoplasms are rare compared with other neurogenic lesions, such as neurofibromaand schwannoma. To our knowledge, ours represents the first case of ganglioneuromaarising in the orbit.

Ganglioneuromas may arise de novo or in patients who have had chemotherapyfor metastatic neuroblastoma. Typically, they enlarge slowly; rapid growthshould raise suspicion for a poorly differentiated neoplasm. Neoplasms ofprimitive neuroectodermal origin, such as neuroblastoma, contain pluripotentcells that have the capacity to differentiate into mature cellular elements,such as ganglion cells.8 When ganglion celldifferentiation is present within an otherwise typical neuroblastoma, theterm ganglioneuroblastoma is appropriate. In the present case, clinical uncertaintyregarding cellular composition coupled with progressive proptosis and itsassociated corneal complication prompted debulking of the lesion. The historyof metastatic neuroblastoma and the presence of multiple ganglioneuromas lendcredence to the theory purporting the presence of rests of metastatic neuroblastomathat subsequently undergo maturation. Ganglioneuromas, as fully differentiatedneoplasms, do not have the capability to metastasize, so extensive surgicalresections or chemotherapy is not normally necessary, provided surgical samplingis sufficient to allow adequate histologic analysis and to assure no neuroblasticcellular elements are present. Excision may be considered when the pathologicdiagnosis is uncertain or visual function is compromised by the neoplasm.

Correspondence: Dr Cannon, University ofArkansas for Medical Sciences, Jones Eye Institute, 4301 W Markham, Slot 523,Little Rock, AR 72205 (tomccannon@aol.com).

Financial Disclosure: None.

Funding/Support: This study was supported inpart by an unrestricted grant from Research to Prevent Blindness Inc, NewYork, NY.

Albonico  GPellegrino  GMaisano  MKardon  DE Ganglioneuroma of parapharyngeal region. Arch Pathol Lab Med 2001;1251217- 1218
PubMed
Joshi  VV Peripheral neuroblastic tumors: pathologic classification based onrecommendations of international neuroblastoma pathology committee (modificationof the Shimada classification). Pediatr Dev Pathol 2000;3184- 199
PubMed Link to Article
Geraci  APde Csepel  JShlasko  EWallace  SA Ganglioneuroblastoma and ganglioneuroma in association with neurofibromatosistype I: report of three cases. J Child Neurol 1998;13356- 358
PubMed Link to Article
Francis  ICFilipic  M Men IIIB and ganglioneuromatosis [comment]. Ophthal Plast Reconstr Surg 2000;18163- 164
Link to Article
Hayes  FAGreen  AARao  BN Clinical manifestations of ganglioneuroma. Cancer 1989;631211- 1214
PubMed Link to Article
Piquet  JJWoillez  MCousin  P Ganglioneurome orbitaire gueri par cobaltotherapie. Bull Soc Ophtalmol Fr 1976;76997- 998
PubMed
Miura  KMineta  HYokota  NTsutsui  Y Olfactory neuroblastoma with epithelial and endocrine differentiationtransformed into ganglioneuroma after chemoradiotherapy. Pathol Int 2001;51942- 947
PubMed Link to Article
Jakobiec  FAKlepach  GLCrissman  JDSpoor  TC Primary differentiated neuroblastoma of the orbit. Ophthalmology 1987;94255- 266
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.

Clinical photograph prior to surgeryshowing proptosis of the right eye.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Axial view of an orbital T1-weightedmagnetic resonance image revealing a superior orbital neoplasm.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Coronal view of an orbital T1-weightedmagnetic resonance image showing a neoplasm without invasion of the bone.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.

bo Gross photograph of the neoplasmshowing a circumscribed lesion with a variegated tan-white surface lackingnecrosis.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 5.

Hematoxylin-eosin staining showingmature ganglion cells within a neurofibrillary matrix and no neuroblastoma(original magnification × 200).

Graphic Jump Location

Tables

References

Albonico  GPellegrino  GMaisano  MKardon  DE Ganglioneuroma of parapharyngeal region. Arch Pathol Lab Med 2001;1251217- 1218
PubMed
Joshi  VV Peripheral neuroblastic tumors: pathologic classification based onrecommendations of international neuroblastoma pathology committee (modificationof the Shimada classification). Pediatr Dev Pathol 2000;3184- 199
PubMed Link to Article
Geraci  APde Csepel  JShlasko  EWallace  SA Ganglioneuroblastoma and ganglioneuroma in association with neurofibromatosistype I: report of three cases. J Child Neurol 1998;13356- 358
PubMed Link to Article
Francis  ICFilipic  M Men IIIB and ganglioneuromatosis [comment]. Ophthal Plast Reconstr Surg 2000;18163- 164
Link to Article
Hayes  FAGreen  AARao  BN Clinical manifestations of ganglioneuroma. Cancer 1989;631211- 1214
PubMed Link to Article
Piquet  JJWoillez  MCousin  P Ganglioneurome orbitaire gueri par cobaltotherapie. Bull Soc Ophtalmol Fr 1976;76997- 998
PubMed
Miura  KMineta  HYokota  NTsutsui  Y Olfactory neuroblastoma with epithelial and endocrine differentiationtransformed into ganglioneuroma after chemoradiotherapy. Pathol Int 2001;51942- 947
PubMed Link to Article
Jakobiec  FAKlepach  GLCrissman  JDSpoor  TC Primary differentiated neuroblastoma of the orbit. Ophthalmology 1987;94255- 266
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 5

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Lhermitte-Duclos disease. J Neurooncol 2007;82(2):183-5.